Cyrille Touzeau, MD;PhD

Professor of Hematology
CHU de Nantes

Poster(s):

• P-087: Characterization of minimal residual disease (MRD) in patients with relapsed/refractory multiple myeloma treated with elranatamab: Analysis of MagnetisMM-3
  Wednesday, September 27, 2023

  1:30 PM – 2:30 PM EEST